CD8A and neoplasm: These CD4+ and CD8+ tumor-induced senescent (TIS)-T cells are characterized by the loss of CD27 and CD28 expression, lack of proliferative capacity, telomere shortening and increment in the expression of senescence-associated molecules such as p53, p21 and p16.